Metropolis Healthcare · NSE: METROPOLIS · BSE: 542650
Q3 FY26 results · Oct–Dec 2025
Metropolis Healthcare reported revenue from operations of ₹405.91 crore (up 25.8% from Q3 FY25) and net profit of ₹42.09 crore (up 33.7% from Q3 FY25) for Q3 FY26 (Oct–Dec 2025), on a consolidated basis.
| Item | Q3 FY26 | Q3 FY25 | YoY | Q2 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 405.91 | 322.77 | +25.8% | 429.19 | −5.4% |
| Other income | 9.02 | 2.56 | +252.8% | 0.89 | +911.8% |
| Total income | 414.93 | 325.32 | +27.5% | 430.08 | −3.5% |
| Profit before tax | 57.16 | 42.34 | +35.0% | 71.03 | −19.5% |
| Net profit for the period | 42.09 | 31.47 | +33.7% | 52.89 | −20.4% |
| Attributable to shareholders of the company | 41.39 | 31.36 | +32.0% | 52.67 | −21.4% |
| EPS, basic (₹) | 7.99 | 6.11 | +30.7% | 10.17 | −21.4% |
| Net margin (%) | 10.4 | 9.8 | 12.3 |
| Item | Q3 FY26 | Q3 FY25 | YoY | Q2 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 334.78 | 296.88 | +12.8% | 355.71 | −5.9% |
| Other income | 2.22 | 3.03 | −26.9% | 2.52 | −12.1% |
| Total income | 337.00 | 299.91 | +12.4% | 358.23 | −5.9% |
| Profit before tax | 42.32 | 36.80 | +15.0% | 62.12 | −31.9% |
| Net profit for the period | 32.03 | 27.40 | +16.9% | 46.63 | −31.3% |
| EPS, basic (₹) | 6.18 | 5.35 | +15.5% | 9.00 | −31.3% |
| Net margin (%) | 9.6 | 9.2 | 13.1 |
Consolidated
- Filed with BSE
- 04 Feb 2026, 17:59 IST
- Board meeting
- 04 Feb 2026
- Period
- 01 Oct 2025 to 31 Dec 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 04 Feb 2026, 17:59 IST
- Board meeting
- 04 Feb 2026
- Period
- 01 Oct 2025 to 31 Dec 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE